Oligonucleotides: FDA drafts clinical pharmacology guidance

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development